Business
Dosing commenced in the ATL1102 toxicology study
Dosing commenced in the ATL1102 toxicology study
About this update from Percheron Therapeutics Limited
[{"type":"text","content":"Percheron Therapeutics Limited has released a press release. View Attachment","length":249,"tagName":"div"}]